Exact Mass: 305.1528

Exact Mass Matches: 305.1528

Found 189 metabolites which its exact mass value is equals to given mass value 305.1528, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

BUPROFEZIN

Pesticide5_Buprofezin_C16H23N3OS_(2Z)-2-(tert-Butylimino)-3-(1-methylethyl)-5-phenyl-1,3,5-thiadiazinan-4-one

C16H23N3OS (305.1562)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10057; ORIGINAL_PRECURSOR_SCAN_NO 10056 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10079; ORIGINAL_PRECURSOR_SCAN_NO 10078 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10113; ORIGINAL_PRECURSOR_SCAN_NO 10111 ORIGINAL_ACQUISITION_NO 10127; CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10127; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10097; ORIGINAL_PRECURSOR_SCAN_NO 10096 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10129; ORIGINAL_PRECURSOR_SCAN_NO 10128

   

Cetraxate

Cetraxate

C17H23NO4 (305.1627)


A cyclohexanecarboxylate ester that consists of 4-(2-carboxyethyl)phenyl cyclohexanecarboxylate bearing an aminomethyl substituent at the 4-position. C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents

   

Convolamine

(8-BROMO-1-NAPHTHYL)METHANOL

C17H23NO4 (305.1627)


Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids

   

Racanisodamine

(6S)-6-Hydroxyhyoscyamine

C17H23NO4 (305.1627)


   
   

Lunacridine

(+/-)-Lunacridine

C17H23NO4 (305.1627)


   

6-Oxolividamine

6-Oxolividamine

C12H23N3O6 (305.1587)


   

4-Oxolividamine

4-Oxolividamine; 3-Deoxy-4-oxoparomamine

C12H23N3O6 (305.1587)


An aminoglycoside that is 4alpha,6alpha-diaminocyclohexane-1beta,2alpha,3beta-triol in which the pro-R hydroxy group has been converted into its 2-amino-2,3-dideoxy-alpha-D-erythro-hexopyranosid-4-ulose derivative.

   

anisodamine

[(3S,6S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1].

   

Syndesine

2-amino-6-[(E)-(5-amino-5-carboxy-2-hydroxypentylidene)amino]-5-hydroxyhexanoic acid

C12H23N3O6 (305.1587)


Syndesine is found in animal foods. Syndesine is an intramolecular crosslink of collagen. An intramolecular crosslink of collagen. Syndesine is found in animal foods.

   

Methionyl-Arginine

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-5-carbamimidamidopentanoic acid

C11H23N5O3S (305.1522)


Methionyl-Arginine is a dipeptide composed of methionine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Arginylmethionine

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanoic acid

C11H23N5O3S (305.1522)


Arginylmethionine is a dipeptide composed of arginine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

3-[(4-carboxy-3-hydroxy-4-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an (2S,3R)-3-hydroxy-2-methylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyhexanedioylcarnitine

3-[(5-carboxy-3-hydroxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


3-hydroxyhexanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyhexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyhexanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyhexanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Ethyl-2-hydroxybutanedioylcarnitine

3-[(3-carboxy-3-ethyl-3-hydroxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


2-Ethyl-2-hydroxybutanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethyl-2-hydroxybutanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethyl-2-hydroxybutanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Ethyl-2-hydroxybutanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoic acid

C17H23NO4 (305.1627)


   

2-((N-(1-(1H-Imidazol-4-yl)-2-propyl)imino)phenylmethyl)phenol

2-({[1-(1H-imidazol-5-yl)propan-2-yl]imino}(phenyl)methyl)phenol

C19H19N3O (305.1528)


   

Applaud

2-Tert-butylimino-3-isopropyl-5-phenyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazin-4-one

C16H23N3OS (305.1562)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Cetraxate

4-(2-Carboxyethyl)phenyl-trans-4-aminomethylcyclohexane carboxylate hydrochloride

C17H23NO4 (305.1627)


   

Anisodamine

7(c)micro-hydroxyhyoscyamine;Raceanisodamine; alpha-(Hydroxymethyl)benzeneacetic acid 6-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; Tropic acid 6-hydroxy-3-tropanyl ester

C17H23NO4 (305.1627)


6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate is a natural product found in Hyoscyamus niger with data available. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Anisodamine has been investigated for the treatment of Intestinal Diseases. 6-Hydroxyhyoscyamine is a natural product found in Duboisia myoporoides, Anisodus tanguticus, and Hyoscyamus albus with data available. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1].

   

Tuberostemoamide

Tuberostemoamide

C17H23NO4 (305.1627)


   

Knightalbinol

Knightalbinol

C17H23NO4 (305.1627)


   
   

7beta-Hydroxyhyoscyamine

(+)-7b-Hydroxyhyoscyamine

C17H23NO4 (305.1627)


   
   

Phellibilidine

Phellibilidine

C17H23NO4 (305.1627)


   

Decarbomethoxy naucl echine

Decarbomethoxy naucl echine

C19H19N3O (305.1528)


   

Goshuyuamide I

Goshuyuamide I

C19H19N3O (305.1528)


   

13-hydroxyisopyrodysinoic acid

13-hydroxyisopyrodysinoic acid

C17H23NO4 (305.1627)


   

18-demethyl-19-hydroxy-Na-demethyl-Nb-methyl-suaveoline|Na, 18-Didemethyl-19-hydroxy-Nb-methylsuavelien

18-demethyl-19-hydroxy-Na-demethyl-Nb-methyl-suaveoline|Na, 18-Didemethyl-19-hydroxy-Nb-methylsuavelien

C19H19N3O (305.1528)


   

AKOS030687758

AKOS030687758

C17H23NO4 (305.1627)


   

SCHEMBL5807496

SCHEMBL5807496

C17H23NO4 (305.1627)


   
   

isophellibilidine

isophellibilidine

C17H23NO4 (305.1627)


   

stemona-lactam P

stemona-lactam P

C17H23NO4 (305.1627)


   

(-)-kunstleramide|(2E,4E)-7-(3,4-dimethoxyphenyl)-N-ethyl-6-(R)-hydroxyhepta-2,4-dienamide

(-)-kunstleramide|(2E,4E)-7-(3,4-dimethoxyphenyl)-N-ethyl-6-(R)-hydroxyhepta-2,4-dienamide

C17H23NO4 (305.1627)


   
   

Physochlain|Physochlaine

Physochlain|Physochlaine

C17H23NO4 (305.1627)


   

norcoronatine

norcoronatine

C17H23NO4 (305.1627)


   

Beta-Naucleonine|Naucleonine

Beta-Naucleonine|Naucleonine

C19H19N3O (305.1528)


   

O3-Demethylhippeastidine

O3-Demethylhippeastidine

C17H23NO4 (305.1627)


   
   
   
   
   
   
   
   

Convolvamine

Convolvamine

C17H23NO4 (305.1627)


Annotation level-1

   
   
   
   
   
   
   
   

Arg-met

2-[2-amino-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanoic acid

C11H23N5O3S (305.1522)


A dipeptide formed from L-arginine and L-methionine residues.

   

Met-arg

2-(2-amino-5-carbamimidamidopentanamido)-4-(methylsulfanyl)butanoic acid

C11H23N5O3S (305.1522)


A dipeptide formed from L-methionine and L-arginine residues.

   

Syndesine

2-amino-6-[(E)-(5-amino-5-carboxy-2-hydroxypentylidene)amino]-5-hydroxyhexanoic acid

C12H23N3O6 (305.1587)


   

4-(4-FORMYL-PHENOXY)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(4-FORMYL-PHENOXY)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

tert-butyl 2-[hydroxy(dimethyl)silyl]-5-methylindole-1-carboxylate

tert-butyl 2-[hydroxy(dimethyl)silyl]-5-methylindole-1-carboxylate

C16H23NO3Si (305.1447)


   

(2S,4S)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

(2S,4S)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-benz oimidazol-2-one

1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-benz oimidazol-2-one

C19H19N3O (305.1528)


   

N-BOC-4-PHENYLNIPECOTIC ACID

N-BOC-4-PHENYLNIPECOTIC ACID

C17H23NO4 (305.1627)


   

4-(4-Carboxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester

4-(4-Carboxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester

C17H23NO4 (305.1627)


   

3-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

3-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   
   

(S)-N-BOC-4-FLUOROPHENYLGLYCINE

(S)-N-BOC-4-FLUOROPHENYLGLYCINE

C17H23NO4 (305.1627)


   

2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

C17H23NO4 (305.1627)


   

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(P-TOLYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(P-TOLYL)PYRROLIDINE-3-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

Cbz-D-Cyclohexylalanine

Cbz-D-Cyclohexylalanine

C17H23NO4 (305.1627)


   

Trimorpholinophosphine oxide

Trimorpholinophosphine oxide

C12H24N3O4P (305.1504)


   

(3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID

(3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID

C15H20BNO5 (305.1434)


   

(3S,4R)-1-tert-butoxycarbonyl-3-phenyl-piperidine-4-carboxylic ac id

(3S,4R)-1-tert-butoxycarbonyl-3-phenyl-piperidine-4-carboxylic ac id

C17H23NO4 (305.1627)


   

BOC--BENZYL-DL-PRO-OH

BOC--BENZYL-DL-PRO-OH

C17H23NO4 (305.1627)


   

3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

C17H23NO4 (305.1627)


   

5-PHENYL-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

5-PHENYL-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

boc-(s)-alpha-benzyl-proline

boc-(s)-alpha-benzyl-proline

C17H23NO4 (305.1627)


   

ETHYL N-CBZ-2-PIPERIDINEACETATE

ETHYL N-CBZ-2-PIPERIDINEACETATE

C17H23NO4 (305.1627)


   

Orphenadrine hydrochloride

Orphenadrine hydrochloride

C18H24ClNO (305.1546)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AB - Ethers chemically close to antihistamines D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents

   

diethyl 1-benzylpyrrolidine-2,5-dicarboxylate

diethyl 1-benzylpyrrolidine-2,5-dicarboxylate

C17H23NO4 (305.1627)


   

Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, conjugate acid(1:1)

Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, conjugate acid(1:1)

C19H19N3O (305.1528)


   

3-(4-tert-butylphenyl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

3-(4-tert-butylphenyl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

C16H23N3OS (305.1562)


   

boc-(r)-alpha-benzyl-proline

boc-(r)-alpha-benzyl-proline

C17H23NO4 (305.1627)


   

H-Ala-Ala-Ala-OMe acetate salt

H-Ala-Ala-Ala-OMe acetate salt

C12H23N3O6 (305.1587)


   

1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-6-phenyl-3-piperidinecarboxylic acid

1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-6-phenyl-3-piperidinecarboxylic acid

C17H23NO4 (305.1627)


   

1-BENZYL 3-ETHYL 3-METHYLPIPERIDINE-1,3-DICARBOXYLATE

1-BENZYL 3-ETHYL 3-METHYLPIPERIDINE-1,3-DICARBOXYLATE

C17H23NO4 (305.1627)


   

1-BENZYL 4-ETHYL 4-METHYLPIPERIDINE-1,4-DICARBOXYLATE

1-BENZYL 4-ETHYL 4-METHYLPIPERIDINE-1,4-DICARBOXYLATE

C17H23NO4 (305.1627)


   

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile

C19H20BNO2 (305.1587)


   

1-Cbz-3-isopropylpiperidine-3-carboxylic Acid

1-Cbz-3-isopropylpiperidine-3-carboxylic Acid

C17H23NO4 (305.1627)


   

Methyl 1-Cbz-3-ethylpiperidine-3-carboxylate

Methyl 1-Cbz-3-ethylpiperidine-3-carboxylate

C17H23NO4 (305.1627)


   

Bifemelane hydrochloride

Bifemelane hydrochloride

C18H24ClNO (305.1546)


   

Boc-(R)-3-Amino-(6-phenyl)-5-hexenoic acid

Boc-(R)-3-Amino-(6-phenyl)-5-hexenoic acid

C17H23NO4 (305.1627)


   

6-((1S)-1-Aminoethyl)-N-(3,4,5-trimethoxyphenyl)-1,2,4-triazin-3-amine

6-((1S)-1-Aminoethyl)-N-(3,4,5-trimethoxyphenyl)-1,2,4-triazin-3-amine

C14H19N5O3 (305.1488)


   

3-TERT-BUTYL 2-METHYL 4,5-DIHYDRO-1H-BENZO[D]AZEPINE-2,3(2H)-DICARBOXYLATE

3-TERT-BUTYL 2-METHYL 4,5-DIHYDRO-1H-BENZO[D]AZEPINE-2,3(2H)-DICARBOXYLATE

C17H23NO4 (305.1627)


   

4-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

4-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

[6-ethoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[6-ethoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C15H20BNO5 (305.1434)


   

N-Benzyloxycarbonyl-L-proline tert-butyl ester

N-Benzyloxycarbonyl-L-proline tert-butyl ester

C17H23NO4 (305.1627)


   

Benzyl 5-hydroxy-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate

Benzyl 5-hydroxy-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate

C17H23NO4 (305.1627)


   

ethyl prop-2-enoate,formaldehyde,prop-2-enamide,styrene

ethyl prop-2-enoate,formaldehyde,prop-2-enamide,styrene

C17H23NO4 (305.1627)


   

2-[(p-methyl-alpha-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride

2-[(p-methyl-alpha-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride

C18H24ClNO (305.1546)


   

2-Naphthaleneacetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,4-tetrahydro

2-Naphthaleneacetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,4-tetrahydro

C17H23NO4 (305.1627)


   

1-phenylmethoxycarbonyl-3-propan-2-ylpiperidine-3-carboxylic acid

1-phenylmethoxycarbonyl-3-propan-2-ylpiperidine-3-carboxylic acid

C17H23NO4 (305.1627)


   
   

CIS-DIETHYL 1-BENZYLPYRROLIDINE-3,4-DICARBOXYLATE

CIS-DIETHYL 1-BENZYLPYRROLIDINE-3,4-DICARBOXYLATE

C17H23NO4 (305.1627)


   

N,N-dimethyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride

N,N-dimethyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride

C18H24ClNO (305.1546)


   

Boc-(S)-3-Amino-(6-phenyl)-5-hexenoic acid

Boc-(S)-3-Amino-(6-phenyl)-5-hexenoic acid

C17H23NO4 (305.1627)


   

tert-Butyl 3-morpholin-3-yl-propionate oxalate

tert-Butyl 3-morpholin-3-yl-propionate oxalate

C13H23NO7 (305.1474)


   

(4-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid

(4-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid

C15H20BNO5 (305.1434)


   

Benzyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate

Benzyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate

C16H23NO3Si (305.1447)


   

Bucumolol

Bucumolol

C17H23NO4 (305.1627)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

Ethyl N-Cbz-4-piperidineacetate

Ethyl N-Cbz-4-piperidineacetate

C17H23NO4 (305.1627)


   

2-Acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

2-Acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

C15H20BNO5 (305.1434)


   

4-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)BENZOIC ACID

4-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)BENZOIC ACID

C17H23NO4 (305.1627)


   

(2S,4R)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

(2S,4R)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

2-PHENYL-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

2-PHENYL-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

1-(TERT-BUTOXYCARBONYL)-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

Atropine oxide

Atropine oxide

C17H23NO4 (305.1627)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

Methionyl-Arginine

Methionyl-Arginine

C11H23N5O3S (305.1522)


   
   

10-Methoxy-9-methyl-8-(3-methylbut-2-enoxy)-1,3,4,5-tetrahydro-2,5-benzoxazocin-6-one

10-Methoxy-9-methyl-8-(3-methylbut-2-enoxy)-1,3,4,5-tetrahydro-2,5-benzoxazocin-6-one

C17H23NO4 (305.1627)


   

3-Hydroxyhexanedioylcarnitine

3-Hydroxyhexanedioylcarnitine

C13H23NO7 (305.1474)


   

2-Ethyl-2-hydroxybutanedioylcarnitine

2-Ethyl-2-hydroxybutanedioylcarnitine

C13H23NO7 (305.1474)


   

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

C13H23NO7 (305.1474)


   

Disipal

Disipal

C18H24ClNO (305.1546)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents

   

Alnert

Alnert

C18H24ClNO (305.1546)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

1-(2,6-Dimethylphenyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]thiourea

1-(2,6-Dimethylphenyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]thiourea

C16H23N3OS (305.1562)


   

(3S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate

(3S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate

C17H23NO4 (305.1627)


   

N-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide

N-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide

C16H23N3OS (305.1562)


   

N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide

N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide

C16H23N3OS (305.1562)


   

3,4-dimethoxybenzoic acid [(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

3,4-dimethoxybenzoic acid [(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

C17H23NO4 (305.1627)


   

(3Z)-3-[(2E,4E,6E)-1-hydroxydodeca-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)pyrrolidine-2,4-dione

(3Z)-3-[(2E,4E,6E)-1-hydroxydodeca-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)pyrrolidine-2,4-dione

C17H23NO4 (305.1627)


   
   
   
   
   
   
   
   
   
   
   
   
   

(3R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

(3R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

C14H25O7- (305.16)


   

(3R,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

(3R,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

C14H25O7- (305.16)


   

(8-Methyl-8-azabicyclo[3.2.1]oct-3-YL) 3,4-dimethoxybenzoate

(8-Methyl-8-azabicyclo[3.2.1]oct-3-YL) 3,4-dimethoxybenzoate

C17H23NO4 (305.1627)


   

N-(2-Acetoxy-2-methylpropionyl)-N-butylbenzamide

N-(2-Acetoxy-2-methylpropionyl)-N-butylbenzamide

C17H23NO4 (305.1627)


   

atropine oxyde

atropine oxyde

C17H23NO4 (305.1627)


   

cetraxate zwitterion

cetraxate zwitterion

C17H23NO4 (305.1627)


Zwitterionic form of cetraxate arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

Arginyl-methionine

Arginyl-methionine

C11H23N5O3S (305.1522)


   

pyranonigrin J

pyranonigrin J

C17H23NO4 (305.1627)


A member of the class of pyrrolidin-2-ones with formula C17H23NO4, originally isolated from Aspergillus niger.

   

6-(hydroxymethyl)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁶]heptadeca-2,13-dien-4-one

6-(hydroxymethyl)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁶]heptadeca-2,13-dien-4-one

C17H23NO4 (305.1627)


   

(1s,3r,5s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

(1s,3r,5s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(1s,3r,5s,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

(1s,3r,5s,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(1r,3s,4s,5s,6r)-3-hydroxy-4-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

(1r,3s,4s,5s,6r)-3-hydroxy-4-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

C17H23NO4 (305.1627)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-phenylpropanoate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-phenylpropanoate

C17H23NO4 (305.1627)


   

(1s,12s,14s)-14-hydroxy-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-4-ium-4-olate

(1s,12s,14s)-14-hydroxy-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-4-ium-4-olate

C17H23NO4 (305.1627)


   

(1'r,2s,2's,3'r,6's)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

(1'r,2s,2's,3'r,6's)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

(1r,3r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-2-hydroxy-3-(4-hydroxyphenyl)propanoate

(1r,3r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-2-hydroxy-3-(4-hydroxyphenyl)propanoate

C17H23NO4 (305.1627)


   

(1s,6s,16s)-6-(hydroxymethyl)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁶]heptadeca-2,13-dien-4-one

(1s,6s,16s)-6-(hydroxymethyl)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁶]heptadeca-2,13-dien-4-one

C17H23NO4 (305.1627)


   

(6e)-7-{[(2s)-1-hydroxy-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}hept-6-enoic acid

(6e)-7-{[(2s)-1-hydroxy-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}hept-6-enoic acid

C17H23NO4 (305.1627)


   

(1s,3s,5s,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-3-hydroxy-2-phenylpropanoate

(1s,3s,5s,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-(4-hydroxyphenyl)propanoate

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-(4-hydroxyphenyl)propanoate

C17H23NO4 (305.1627)


   

(1's,2r,2'r,3's,6'r)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

(1's,2r,2'r,3's,6'r)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

{9a-hydroxy-4,4,7-trimethyl-2-oxo-4ah,5h,6h,8ah,9h-cyclohexa[f]indol-1-yl}acetic acid

{9a-hydroxy-4,4,7-trimethyl-2-oxo-4ah,5h,6h,8ah,9h-cyclohexa[f]indol-1-yl}acetic acid

C17H23NO4 (305.1627)


   

n-methyl-2-{1h,3h,4h,9h-pyrido[3,4-b]indole-2-carbonyl}aniline

n-methyl-2-{1h,3h,4h,9h-pyrido[3,4-b]indole-2-carbonyl}aniline

C19H19N3O (305.1528)


   

(s)-lunacridine

(s)-lunacridine

C17H23NO4 (305.1627)


   

(1s,2s)-1-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-2-methylcyclopropane-1-carboxylic acid

(1s,2s)-1-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-2-methylcyclopropane-1-carboxylic acid

C17H23NO4 (305.1627)


   

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-(2-hydroxyphenyl)propanoate

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-(2-hydroxyphenyl)propanoate

C17H23NO4 (305.1627)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-methoxyphenyl)acetate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-methoxyphenyl)acetate

C17H23NO4 (305.1627)


   

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-methoxyphenyl)acetate

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-methoxyphenyl)acetate

C17H23NO4 (305.1627)


   

(1s,2r,3s,4s,6r)-3-methyl-4-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-11-one

(1s,2r,3s,4s,6r)-3-methyl-4-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-11-one

C17H23NO4 (305.1627)


   

(1r,5r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

(1r,5r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(1's,2'r,3's,6'r)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

(1's,2'r,3's,6'r)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(1s,2r,3s,4s,6r)-3-methyl-4-[(2s)-4-methyl-5-oxo-2h-furan-2-yl]-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-11-one

(1s,2r,3s,4s,6r)-3-methyl-4-[(2s)-4-methyl-5-oxo-2h-furan-2-yl]-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-11-one

C17H23NO4 (305.1627)


   

2-(2-hydroxyethyl)-4-methoxy-5-methyl-6-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindol-1-one

2-(2-hydroxyethyl)-4-methoxy-5-methyl-6-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindol-1-one

C17H23NO4 (305.1627)


   

3-hydroxy-4-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

3-hydroxy-4-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

C17H23NO4 (305.1627)


   

10-methoxy-9-methyl-8-[(3-methylbut-2-en-1-yl)oxy]-3,4-dihydro-1h-2,5-benzoxazocin-6-ol

10-methoxy-9-methyl-8-[(3-methylbut-2-en-1-yl)oxy]-3,4-dihydro-1h-2,5-benzoxazocin-6-ol

C17H23NO4 (305.1627)


   

(1'r,2r,2's,3'r,6's)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

(1'r,2r,2's,3'r,6's)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

(1s,3r,4s,5r,6r)-3-hydroxy-4-[(r)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

(1s,3r,4s,5r,6r)-3-hydroxy-4-[(r)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

C17H23NO4 (305.1627)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(6r,9r,9as)-9-hydroxy-6-(2-hydroxypropan-2-yl)-9-methyl-6h,7h,8h,9ah,10h-pyrido[1,2-a]indole-2-carboxylic acid

(6r,9r,9as)-9-hydroxy-6-(2-hydroxypropan-2-yl)-9-methyl-6h,7h,8h,9ah,10h-pyrido[1,2-a]indole-2-carboxylic acid

C17H23NO4 (305.1627)


   

1-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-2-methylcyclopropane-1-carboxylic acid

1-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-2-methylcyclopropane-1-carboxylic acid

C17H23NO4 (305.1627)


   

3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

(3z)-1-hydroxy-3-[(2e,4e,6e)-1-hydroxytrideca-2,4,6-trien-1-ylidene]pyrrolidine-2,4-dione

(3z)-1-hydroxy-3-[(2e,4e,6e)-1-hydroxytrideca-2,4,6-trien-1-ylidene]pyrrolidine-2,4-dione

C17H23NO4 (305.1627)